Accufy Diagnostics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-28.
Accufy Diagnostics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 28, 2026. The filing reports $2M sold. Its industry group is Biotechnology. It names Jeffrey Hung (Executive Officer, Director), Zhixiong Xu (Executive Officer, Director) (SEC Form D, October 28, 2026).
Selling to Accufy Diagnostics, Inc.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like Accufy Diagnostics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Accufy Diagnostics, Inc.
Free to see. No signup.
More on the people and the money behind Accufy Diagnostics, Inc., from the filings we hold.
Biotechnology raises by companies based in Maryland, filed in October 2026, largest first.
Get an email when Accufy Diagnostics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Accufy Diagnostics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Accufy Diagnostics, Inc. →Get the full cited report on Accufy Diagnostics, Inc.
What the filing shows about Accufy Diagnostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Accufy Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Accufy Diagnostics, Inc.'s address as 13 Taft Court, Suite 219, Rockville, MD 20850.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Accufy Diagnostics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Accufy Diagnostics, Inc. See pricing
Accufy Diagnostics, Inc. is a registered filer with the SEC (CIK 2089723) and has filed since 2025-10-02. 2 filings are on record, the latest on 2026-10-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Accufy Diagnostics, Inc.'s Form D of 2026-10-28 names Jeffrey Hung and Zhixiong Xu as its officers, directors or promoters.
Its new offerings report $2.20M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $2M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Jeffrey Hung is named as Executive Officer and Director on the Form D that Accufy Diagnostics, Inc. filed with the SEC on 28 October 2026, one of 2 people that filing names.
Zhixiong Xu is named as Executive Officer and Director on the Form D that Accufy Diagnostics, Inc. filed with the SEC on 28 October 2026, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2026-10-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Accufy Diagnostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Accufy Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Accufy Diagnostics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Accufy Diagnostics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Accufy Diagnostics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Accufy Diagnostics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-10-26 · Biotech raises in Washington, DC
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/accufy-diagnostics-inc-form-d-000001